|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|
| Cash Flows from Operating Activities: | |
| Net income (loss) | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| Interest earned on investments held in Trust Account | |
| Change in fair value of warrant liability and derivative asset - forward purchase agreement, net | |
| Offering costs allocated to warrants | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Due from Sponsor | |
| Accrued expenses | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activities: | |
| Investment of cash in Trust Account | |
| Net cash used in investing activities | |
| Cash Flows from Financing Activities: | |
| Proceeds from initial public offering | |
| Proceeds from private placement | |
| Payment of underwriter discount at IPO | |
| Proceeds from promissory note - related party | |
| Payment of deferred offering costs | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash, beginning of period | |
| Cash, end of the period | |
| Supplemental disclosure of cash flow information: | |
| Offering costs included in accrued offering costs and expenses | |
| Issuance of representative shares | |
| Deferred underwriting commissions payable charged to additional paid in capital | |
| Repayment of promissory note - related party through reduction in proceeds from private placement |
Loading...
